BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26765965)

  • 1. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival.
    Arnachellum RP; Cariou M; Nousbaum JB; Jezequel J; Le Reste JY; Robaszkiewicz M
    Pancreas; 2016 Aug; 45(7):953-60. PubMed ID: 26765965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy.
    Kasumova GG; Eskander MF; de Geus SWL; Neto MM; Tabatabaie O; Ng SC; Miksad RA; Mahadevan A; Rodrigue JR; Tseng JF
    Surgery; 2017 Aug; 162(2):275-284. PubMed ID: 28487044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient characteristics and treatment considerations in pancreatic cancer: a population based study in the Netherlands.
    Zijlstra M; van der Geest LGM; van Laarhoven HWM; Lemmens VEPP; van de Poll-Franse LV; Raijmakers NJH
    Acta Oncol; 2018 Sep; 57(9):1185-1191. PubMed ID: 29741436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.
    Shirai Y; Shiba H; Haruki K; Horiuchi T; Saito N; Fujiwara Y; Sakamoto T; Uwagawa T; Yanaga K
    Anticancer Res; 2017 Feb; 37(2):787-793. PubMed ID: 28179331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic management and survival of gastric adenocarcinoma in the province of Finistère between 1984 and 1989].
    Le Page M; Cauvin JM; Le Dréau G; Nousbaum JB; Enard L; Gourlaouen A; Robaszkiewicz M; Gouérou H
    Gastroenterol Clin Biol; 1995 Oct; 19(10):804-10. PubMed ID: 8566560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and outcomes of pancreatectomy in patients with metastatic pancreatic adenocarcinoma.
    McKenzie S; Mailey B; Artinyan A; Kim J; Ellenhorn JD
    JOP; 2010 Jul; 11(4):341-7. PubMed ID: 20601808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer: incidence, treatment and survival trends--1175 cases in Calvados (France) from 1978 to 2002.
    Lefebvre AC; Maurel J; Boutreux S; Bouvier V; Reimund JM; Launoy G; Arsene D
    Gastroenterol Clin Biol; 2009; 33(10-11):1045-51. PubMed ID: 19773140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma.
    Lee SR; Kim HO; Son BH; Yoo CH; Shin JH
    Hepatogastroenterology; 2013; 60(122):358-62. PubMed ID: 23574658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic status impacts survival and access to resection in pancreatic adenocarcinoma: A high-resolution population-based cancer registry study.
    Thobie A; Mulliri A; Dolet N; Eid Y; Bouvier V; Launoy G; Alves A; Dejardin O
    Surg Oncol; 2018 Dec; 27(4):759-766. PubMed ID: 30449504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986-2009: a population-based study.
    Jonsdottir SB; Juliusson G; Kristinsson JÖ; Hreinsson JP; Jonasson JG; Björnsson ES
    Scand J Gastroenterol; 2018 Jan; 53(1):100-106. PubMed ID: 29058490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiation for resected pancreatic adenocarcinoma with or without intraoperative radiation therapy boost: Long-term outcomes.
    Calvo FA; Sole CV; Atahualpa F; Lozano MA; Gomez-Espi M; Calin A; García-Alfonso P; Gonzalez-Bayon L; Herranz R; García-Sabrido JL
    Pancreatology; 2013; 13(6):576-82. PubMed ID: 24280572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of histological response after neoadjuvant chemoradiotherapy on recurrence-free survival in UICC-T3 pancreatic adenocarcinoma but not in UICC-T4.
    Murata Y; Mizuno S; Kishiwada M; Hamada T; Usui M; Sakurai H; Tabata M; Inoue H; Shiraishi T; Isaji S
    Pancreas; 2012 Jan; 41(1):130-6. PubMed ID: 21934551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.